Form D · Pharmaceuticals
Magna Pharmaceuticals, Inc.
Louisville, KY · CIK 0001596152
Offering snapshot reported May 21, 2014 · SEC filing
- Reported sold
- $499K Offering amount: $3.75M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $3.75K Reported outside-investor minimum
- First sale
- Dec 30, 2013 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$1,005,536 → $499,016
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 21, 2014 | Amendment | $499,016 | -$506,520vs Jan 10, 2014 | 1 | SEC filing |
| Jan 10, 2014 | Initial | $1,005,536 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 05, 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-209717
Subscription Agreement for purchase of $1,001,784 worth of stock in monthly increments; purchaser has purchased only $499,016 worth of stock. Option for purchase of additional shares for $2,750,216. Option to be exercised on or before August 1, 2014.
Source: Form D, filed May 21, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Warren Paul Lesser | Director, Executive, Promoter |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
10801 Electron Drive Suite 100
Louisville, KY, 40299
Louisville, KY, 40299